BREAKING
Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 2 days ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 2 days ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 2 days ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 3 days ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 3 days ago Abbott reports positive results from study on its atrial fibrillation therapies 3 days ago Atmus Welcomes Heath Sharp to Board of Directors 3 days ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 3 days ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 5 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 5 days ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 2 days ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 2 days ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 2 days ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 3 days ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 3 days ago Abbott reports positive results from study on its atrial fibrillation therapies 3 days ago Atmus Welcomes Heath Sharp to Board of Directors 3 days ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 3 days ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 5 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 5 days ago
ADVERTISEMENT
Market News

Wall St hits bulls-eye with Colgate-Palmolive Q2 estimates

Consumer goods company Colgate-Palmolive (NYSE: CL) on Friday reported second-quarter results that were in line with the Wall Street projections. Q2 revenues of $3.87 billion, which were almost flat year-over-year, were hurt by higher raw material and advertising costs, as well as currency headwinds. Analysts had projected Q2 revenues of $3.88 billion. Earnings, on an […]

July 26, 2019 2 min read

Consumer goods company Colgate-Palmolive (NYSE: CL) on Friday reported second-quarter results that were in line with the Wall Street projections.

Q2 revenues of $3.87 billion, which were almost flat year-over-year, were hurt by higher raw material and advertising costs, as well as currency headwinds. Analysts had projected Q2 revenues of $3.88 billion.

Earnings, on an adjusted basis, fell 6% to 72 cents per share, in line with the street estimates.

Q2 revenues of $3.87 billion, which were almost flat year-over-year, were hurt by higher raw material and advertising costs,

Colgate stock gained 1% following the announcement of the results. CL shares have gained 22% so far this year.

READ: Alphabet reverses ad revenue deceleration trend in Q2, stock rises

ADVERTISEMENT

In North America, despite revenues increasing 2.5% year-over-year,
operating profits were down 4%. This was primarily due to higher raw and
packaging material costs, partially offset by cost savings from the company’s
funding-the-growth initiatives.

CEO Noel Wallace said, “Colgate’s leadership of the global toothpaste market continued during the quarter with our global market share at 41.4% year to date. Our global leadership in manual toothbrushes also continued with Colgate’s global market share in that category at 31.7% year to date.”

Outlook

The
company continues to expect 2019 net sales to be flat to up low-single-digits,
with organic sales up between 2% and 4%.

Excluding certain one-time costs, Colgate continue to plan for a year of
gross margin expansion, increased advertising investment and a mid-single-digit
decline in earnings per share.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

ADVERTISEMENT
ADVERTISEMENT